Pacific Biosciences Of California (PACB) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.85 Bn | 8.34 Bn | 2.33 Bn |
| 2 | Danaher | 144.67 Bn | 140.33 Bn | 3.61 Bn | 2.07 Bn |
| 3 | Agilent Technologies | 41.02 Bn | 39.26 Bn | 1.04 Bn | 475.00 Mn |
| 4 | Illumina | 31.29 Bn | 30.12 Bn | 770.00 Mn | 273.00 Mn |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | 278.58 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 113.17 Mn |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | 212.00 Mn |
| 8 | Repligen | 9.31 Bn | 8.29 Bn | 110.04 Mn | 76.62 Mn |
| 9 | 10x Genomics | 8.66 Bn | 8.10 Bn | 112.50 Mn | 78.66 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 33.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.39 Mn |
| Mar 31, 2026 | 31.15 Mn |
| Dec 31, 2025 | 34.05 Mn |
| Sep 30, 2025 | 31.10 Mn |
| Jun 30, 2025 | 36.18 Mn |
| Mar 31, 2025 | 40.17 Mn |
| Dec 31, 2024 | 41.64 Mn |
| Sep 30, 2024 | 43.75 Mn |
| Jun 30, 2024 | 45.88 Mn |
| Mar 31, 2024 | 43.75 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Sep 30, 2023 | 43.43 Mn |
| Jun 30, 2023 | 40.57 Mn |
| Mar 31, 2023 | 39.82 Mn |
| Dec 31, 2022 | 45.00 Mn |
| Sep 30, 2022 | 36.80 Mn |
| Jun 30, 2022 | 39.25 Mn |
| Mar 31, 2022 | 39.80 Mn |
| Dec 31, 2021 | 37.32 Mn |
| Jun 30, 2021 | 29.06 Mn |